@inproceedings{oai:repo.qst.go.jp:00078361,
 author = {水島, 康太 and 阿部, 康志 and 稲庭, 拓 and 岩田, 佳之 and 浦田, 昌身 and 片桐, 健 and 北川, 敦志 and 早乙女, 直也 and 佐藤, 眞二 and 高田, 栄一 and 野田, 悦夫 and 原, 洋介 and 古川, 卓司 and 村松, 正幸 and Sung Hyun, Lee and 白井, 敏之 and 大内, 章央 and 川島 祐洋 and 小林 千広 and 田久保 篤 and 中島, 猛雄 and 藤本 哲也 and 若勇, 充司 and Mizushima, Kota and Abe, Yasushi and Inaniwa, Taku and Iwata, Yoshiyuki and Urata, Masami and Katagiri, Ken and Kitagawa, Atsushi and Saotome, Naoya and Sato, Shinji and Takada, Eiichi and Noda, Etsuo and Hara, Yousuke and Furukawa, Takuji and Muramatsu, Masayuki and Sung-Hyun, Lee and Shirai, Toshiyuki},
 book = {2019年第16回日本加速器学会年会プロシーディングス},
 month = {Aug},
 note = {Heavy-ion  radiotherapy  with  the  Heavy  ion  Medical  Accelerator  synchrotron  in  Chiba  (HIMAC)  has  been administered  to  more  than  12,000  patients  since  1994.  We  started  the  heavy-ion  radiotherapy  with  a  3D  scanning 
irradiation system in 2011 and using a superconducting-rotating gantry in 2017, at a new treatment research facility in NIRS.  We  have  continued  some  R&Ds  on  HIMAC  to  enhance  the  treatment  quality  and  to  improve  the  treatment 
results. Since 2016, we have started developments of a compact superconducting rotating gantry and synchrotron to be applied  for  a  newly  started  project  of  a  “quantum  scalpel”  that  is  a  next  generation  of  the  heavy-ion  radiotherapy machine. This paper outlines those R&Ds as well as the present status of HIMAC facility.},
 pages = {1266--1269},
 title = {HIMAC加速器の現状報告(2019)},
 year = {2019}
}